Compare IOVA & FSUN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IOVA | FSUN |
|---|---|---|
| Founded | 2007 | 1892 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 968.6M | 966.0M |
| IPO Year | N/A | N/A |
| Metric | IOVA | FSUN |
|---|---|---|
| Price | $2.22 | $35.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 3 |
| Target Price | $10.36 | ★ $45.67 |
| AVG Volume (30 Days) | ★ 16.6M | 131.1K |
| Earning Date | 11-06-2025 | 10-27-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 3.52 |
| EPS | N/A | ★ 3.16 |
| Revenue | $250,425,000.00 | ★ $384,497,000.00 |
| Revenue This Year | $60.94 | $18.64 |
| Revenue Next Year | $60.85 | $49.01 |
| P/E Ratio | ★ N/A | $10.96 |
| Revenue Growth | ★ 175.62 | 10.48 |
| 52 Week Low | $1.64 | $29.95 |
| 52 Week High | $9.30 | $45.32 |
| Indicator | IOVA | FSUN |
|---|---|---|
| Relative Strength Index (RSI) | 47.43 | 56.07 |
| Support Level | $2.13 | $33.41 |
| Resistance Level | $2.55 | $34.50 |
| Average True Range (ATR) | 0.16 | 1.07 |
| MACD | -0.03 | 0.53 |
| Stochastic Oscillator | 25.57 | 97.36 |
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.
Firstsun Capital Bancorp is the financial holding company. It provides a full range of deposit, lending, treasury management, wealth management, and online banking products and services. The company operates in two segments - Banking operations and mortgage operations, the majority of which are generated by the banking operations segment. The Banking segment originates loans and provides deposits and fee based services to consumer, business, and mortgage lending customers. Products offered include a full range of commercial and consumer banking and financial services. The Mortgage Operations segment originates, sells, services, and manages market risk from changes in interest rates on one-to-four family residential mortgage loans.